Tech News
Back to home
Technology

The Download: how humans make decisions, and Moderna’s “vaccine” word games

Source

MIT Technology Review

Published

TL;DR

AI Generated

The article discusses how humans make decisions, with Uri Maoz, a professor of computational neuroscience, exploring the connection between desires, beliefs, and actions. Moderna's use of mRNA technology for cancer treatment is causing a debate over whether to label it a "vaccine" or "therapy." The company's decision to rebrand it as an "individualized neoantigen therapy" aims to avoid vaccine-related controversies. Additionally, the article highlights other tech news, including attacks on Sam Altman's home, the AI arms race, and Apple's development of smart glasses.

Read Full Article

Similar Articles

MIT Technology Review

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

Moderna is facing a dilemma over whether to call its cancer treatment a "vaccine" or a "therapy" to distance itself from vaccine skepticism. The company's mRNA technology is being used in partnership with Merck to develop individualized neoantigen therapy for cancer treatment. Despite the promising results, some are concerned that patients may be misled by the terminology change. Moderna's strategy to rebrand its cancer treatment may be a response to government scrutiny over its mRNA vaccines. The debate over terminology reflects the broader challenges in navigating public perception and regulatory hurdles in the biotech industry.

MIT Technology Review•
MIT Technology Review

The Download: glass chips and “AI-free” logos

Glass chips for AI are on the horizon as a South Korean company, Absolics, plans to produce special glass panels for next-gen computing hardware. This innovation could lead to more powerful and energy-efficient AI chips in data centers, laptops, and mobile devices. Meanwhile, organizations are racing to create a universally recognized "AI-free" logo, and Elizabeth Warren is seeking answers on xAI's access to military data. Additionally, Meta is planning significant layoffs, ByteDance delayed a video AI model launch due to copyright disputes, and a Chinese AI startup is now valued at $18 billion.

MIT Technology Review•
MIT Technology Review

A new way to rejuvenate the immune system

Researchers at MIT and the Broad Institute have discovered a new method to rejuvenate the immune system by stimulating the liver to produce signals that typically come from the thymus. By encoding key factors promoting T-cell maturation into mRNA sequences delivered via lipid nanoparticles, the liver can be temporarily programmed to enhance T-cell function. In aged mice, this treatment led to larger and more diverse T-cell populations, resulting in improved responses to vaccination and cancer immunotherapy. If this approach is successful in humans, it could potentially help individuals maintain better health and disease resistance as they age.

MIT Technology Review•
Inventor showcases 3D printer filament dryer that mines Bitcoins and dries filament with waste heat, capable of 6 TH/s at 140W — joins Bitcoin-mining 3D printer in hobbyist-focused miner lineup

Inventor showcases 3D printer filament dryer that mines Bitcoins and dries filament with waste heat, capable of 6 TH/s at 140W — joins Bitcoin-mining 3D printer in hobbyist-focused miner lineup

An inventor has created a filament dryer that not only dries filament for 3D printing but also mines Bitcoins, utilizing waste heat from the process. This new prototype is capable of 6 TH/s at 140W and is part of a lineup of hobbyist-focused mining devices. The filament dryer helps prevent common printing issues caused by moisture absorption and offers a proactive solution for maintaining filament quality. It is likely that this new device shares underlying technology with the inventor's previous 3D printer that also doubled as a Bitcoin miner, hinting at further scalability and innovation in this unique niche market.

Tom's Hardware•

We use cookies

We use cookies to ensure you get the best experience on our website. For more information on how we use cookies, please see our cookie policy.